EtDO-P4
Modify Date: 2024-01-06 16:00:10
EtDO-P4 structure
|
Common Name | EtDO-P4 | ||
|---|---|---|---|---|
| CAS Number | 245329-78-6 | Molecular Weight | 516.75600 | |
| Density | 1.05g/cm3 | Boiling Point | 684.419ºC at 760 mmHg | |
| Molecular Formula | C31H52N2O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 367.723ºC | |
Use of EtDO-P4EtDO-P4 is a nanomolar inhibitor of glycosphingolipid (GSL) synthesis. EtDO-P4 suppresses activation of the EGFR-induced ERK pathway and various receptor tyrosine kinases (RTKs). EtDO-P4 can be used for various types of cancer, including Burkitt’s lymphoma[1]. |
| Name | N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]hexadecanamide |
|---|---|
| Synonym | More Synonyms |
| Description | EtDO-P4 is a nanomolar inhibitor of glycosphingolipid (GSL) synthesis. EtDO-P4 suppresses activation of the EGFR-induced ERK pathway and various receptor tyrosine kinases (RTKs). EtDO-P4 can be used for various types of cancer, including Burkitt’s lymphoma[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.05g/cm3 |
|---|---|
| Boiling Point | 684.419ºC at 760 mmHg |
| Molecular Formula | C31H52N2O4 |
| Molecular Weight | 516.75600 |
| Flash Point | 367.723ºC |
| Exact Mass | 516.39300 |
| PSA | 71.03000 |
| LogP | 6.88190 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.524 |
| D-threo-1-(3',4'-Ethylenedioxy)phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol |
| Hexadecanamide,N-[(1R,2R)-2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl] |